[go: up one dir, main page]

AT275037B - Verfahren zur Herstellung von Mitteln zur Hemmung von Immunitätsreaktionen - Google Patents

Verfahren zur Herstellung von Mitteln zur Hemmung von Immunitätsreaktionen

Info

Publication number
AT275037B
AT275037B AT926367A AT926367A AT275037B AT 275037 B AT275037 B AT 275037B AT 926367 A AT926367 A AT 926367A AT 926367 A AT926367 A AT 926367A AT 275037 B AT275037 B AT 275037B
Authority
AT
Austria
Prior art keywords
agents
manufacture
immune reactions
inhibiting immune
inhibiting
Prior art date
Application number
AT926367A
Other languages
German (de)
English (en)
Original Assignee
Nat Res Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat Res Dev filed Critical Nat Res Dev
Application granted granted Critical
Publication of AT275037B publication Critical patent/AT275037B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02Enzymes or microbial cells immobilised on or in an organic carrier
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/643Albumins, e.g. HSA, BSA, ovalbumin or a Keyhole Limpet Hemocyanin [KHL]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22Ribonucleases RNAses, DNAses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT926367A 1966-10-12 1967-10-12 Verfahren zur Herstellung von Mitteln zur Hemmung von Immunitätsreaktionen AT275037B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB45695/66A GB1136039A (en) 1966-10-12 1966-10-12 Improvements relating to immunosuppressive agents

Publications (1)

Publication Number Publication Date
AT275037B true AT275037B (de) 1969-10-10

Family

ID=10438194

Family Applications (1)

Application Number Title Priority Date Filing Date
AT926367A AT275037B (de) 1966-10-12 1967-10-12 Verfahren zur Herstellung von Mitteln zur Hemmung von Immunitätsreaktionen

Country Status (6)

Country Link
AT (1) AT275037B (xx)
BE (1) BE705035A (xx)
ES (1) ES345979A1 (xx)
FR (2) FR1552939A (xx)
GB (1) GB1136039A (xx)
NL (1) NL6713800A (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4043869A (en) 1972-07-13 1977-08-23 Koch-Light Laboratories, Ltd. Water insoluble biologically active material
ES2759252T3 (es) 2013-10-31 2020-05-08 Resolve Therapeutics Llc Fusiones y métodos terapéuticos de nucleasa-albúmina

Also Published As

Publication number Publication date
FR7058M (xx) 1969-06-23
BE705035A (xx) 1968-04-12
GB1136039A (en) 1968-12-11
NL6713800A (xx) 1968-04-16
ES345979A1 (es) 1968-12-01
FR1552939A (xx) 1969-01-10

Similar Documents

Publication Publication Date Title
CH487916A (de) Verfahren zur Herstellung von 2-Cycloalkylamino-oxazolinen
CH484108A (de) Verfahren zur Herstellung von Pyrrylaminoäthanolen
CH490294A (de) Verfahren zur Herstellung von 3-Methylpentenen
CH485731A (de) Verfahren zur Herstellung von 3-Amino-4-carboxamidopyrazol
CH479626A (de) Verfahren zur Herstellung von Organooxysilanen
CH484016A (de) Verfahren zur Herstellung von Hydrindacenen
CH491064A (de) Verfahren zur Herstellung von Diaceton-L-sorbose
CH487177A (de) Verfahren zur Herstellung von Thiaimidazolidinen
CH484155A (de) Verfahren zur Herstellung von 6-Amino-uracil-5-carbonamid-N-sulfonamiden
CH491857A (de) Verfahren zur Herstellung von Phenoxyaminoalkanolen
AT275037B (de) Verfahren zur Herstellung von Mitteln zur Hemmung von Immunitätsreaktionen
CH490358A (de) Verfahren zur Herstellung von 17a-Äthinyl-17B-hydroxysteroiden
CH472381A (de) Verfahren zur Herstellung von Monohalogeno- azeto-azetamiden
AT277957B (de) Verfahren zur Herstellung von Alkenonen
CH490377A (de) Verfahren zur Herstellung von Aminohydrinen
CH495333A (de) Verfahren zur Herstellung von Trihalogenäthylglycinaten
CH477470A (de) Verfahren zur Herstellung von Ribofuranosiden
CH487860A (de) Verfahren zur Herstellung von Arylsulfonylsemicarbaziden
CH509249A (de) Verfahren zur Herstellung von 3-Aminoalkyl-3-arylindanolen-1
CH506556A (de) Verfahren zur Herstellung von Chinolylmethylpenicillinen
CH480435A (de) Verfahren zur Herstellung von N-Demethyl-N-äthyllincomycin C
AT276763B (de) Verfahren zur Herstellung von Polyacyloxamidrazonen
AT273165B (de) Verfahren zur Herstellung von Diphenylsilandiolen
AT269873B (de) Verfahren zur Herstellung von 2-Nitroimidazolen
AT274780B (de) Verfahren zur Herstellung von 1-Acylaminoadamantanen